hydroxyproline has been researched along with Kidney Diseases in 35 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The simple postabsorptive urine hydroxyproline (Spot-HYPRO) with dialyzable and non-dialyzable (ND) fractions was measured in 28 patients with multiple myeloma." | 7.66 | The postabsorptive urinary hydroxyproline (spot-HYPRO) in patients with multiple myeloma. ( Neely, CL; Niell, HB; Palmieri, GM, 1981) |
| "Serum proline iminopeptidase and (where possible) urinary hydroxyproline were determined in 214 subjects: normal subjects, subjects with chronic kidney disease, subjects with chronic liver disease, subjects with osteitis deformans, subjects with rheumatoid arthritis, and subjects with osteoporosis." | 3.66 | [Rarefying osteopathy in rheumatology. Methods of evaluation and comparison of urinary hydroxyproline and serum proline iminopeptidase]. ( Carrozzo, M; D'Amore, M; Martiradonna, A; Quarto, S; Terlizzi, N, 1980) |
| "The simple postabsorptive urine hydroxyproline (Spot-HYPRO) with dialyzable and non-dialyzable (ND) fractions was measured in 28 patients with multiple myeloma." | 3.66 | The postabsorptive urinary hydroxyproline (spot-HYPRO) in patients with multiple myeloma. ( Neely, CL; Niell, HB; Palmieri, GM, 1981) |
| "The renal excretion of 3-hydroxyproline (3-HYP), an isomer of 4-hydroxyproline (4-HYP) found 6-10 times more in basement membrane collagen than in interstitial collagen, was investigated in control subjects and in 58 adult patients with various kidney diseases." | 3.66 | Urinary 3-hydroxyproline in renal disease. ( Birembaut, P; Borel, PJ; Brunois, JP; Chanard, J; Szymanowicz, A; Toupance, O, 1980) |
| "Betaine treatment significantly attenuated arsenic-induced decrease in renal eNOS expression." | 1.72 | Betaine attenuates sodium arsenite-induced renal dysfunction in rats. ( Kaur, T; Pathak, D; Sharma, AK; Sharma, S; Singh, AP; Singh, B; Yadav, HN, 2022) |
| "Kidney fibrosis is a common process that leads to the progression of various types of kidney disease." | 1.38 | A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. ( Chen, EY; Chen, N; Chuang, PY; D'Agati, V; Dai, Y; Fan, Y; He, JC; Jin, Y; Ma'ayan, A; Mazloom, AR; Ratnam, K; Ross, MJ; Xiong, H; Zhong, Y, 2012) |
| " Clinical chemistry and histopathology indicated male rats were slightly more affected than female rats following dosing with the 120 and 180 ppm formulations; hydroxyproline excretion also supports this finding." | 1.38 | Metabolomics evaluation of hydroxyproline as a potential marker of melamine and cyanuric acid nephrotoxicity in male and female Fischer F344 rats. ( Beger, RD; Bhattacharyya, S; Gamboa da Costa, G; Pence, LM; Schnackenberg, LK; Sun, J, 2012) |
| "Fibrosis is a hallmark of progressive organ disease." | 1.34 | Blockade of IP-10/CXCR3 promotes progressive renal fibrosis. ( Furuichi, K; Gerard, C; Haino, M; Ishida, Y; Kaneko, S; Kawachi, H; Kitagawa, K; Kondo, T; Matsushima, K; Nakaya, I; Narumi, S; Sakai, N; Shimizu, F; Sugaya, T; Wada, T; Yokoyama, H, 2007) |
| "Alport's syndrome is characterised by morphological and structural changes of the renal basement membranes." | 1.28 | Urinary 3-hydroxyproline excretion in Alport's syndrome: a non-invasive screening test? ( Bartosch, B; Lubec, G; Popow, C; Vycudilik, W, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (57.14) | 18.7374 |
| 1990's | 1 (2.86) | 18.2507 |
| 2000's | 3 (8.57) | 29.6817 |
| 2010's | 9 (25.71) | 24.3611 |
| 2020's | 2 (5.71) | 2.80 |
| Authors | Studies |
|---|---|
| Han, L | 1 |
| Zou, Y | 1 |
| Yu, C | 1 |
| Sharma, S | 1 |
| Kaur, T | 1 |
| Sharma, AK | 1 |
| Singh, B | 1 |
| Pathak, D | 1 |
| Yadav, HN | 1 |
| Singh, AP | 1 |
| Ren, J | 1 |
| Zhang, J | 1 |
| Rudemiller, NP | 1 |
| Griffiths, R | 1 |
| Wen, Y | 1 |
| Lu, X | 2 |
| Privratsky, JR | 1 |
| Gunn, MD | 1 |
| Crowley, SD | 1 |
| Sharma, A | 1 |
| Hye Khan, MA | 1 |
| Levick, SP | 1 |
| Lee, KS | 1 |
| Hammock, BD | 1 |
| Imig, JD | 1 |
| Fang, J | 1 |
| Wang, W | 1 |
| Sun, S | 1 |
| Wang, Y | 1 |
| Li, Q | 1 |
| Qiu, M | 1 |
| Zhang, Y | 2 |
| Wang, QL | 1 |
| Yuan, JL | 1 |
| Tao, YY | 1 |
| Liu, P | 1 |
| Liu, CH | 1 |
| Okumura, N | 1 |
| Sudo, K | 1 |
| Takao, T | 1 |
| Nakanishi, T | 1 |
| Morokata, T | 1 |
| Noto, T | 1 |
| Kubo, K | 1 |
| Umeno, H | 1 |
| Kinugasa, F | 1 |
| Eikyu, Y | 1 |
| Kozuki, Y | 1 |
| Seki, N | 1 |
| Schmaderer, C | 1 |
| Xing, CJ | 1 |
| Anderson, G | 1 |
| Hermans, R | 1 |
| Lutz, J | 1 |
| Heemann, U | 1 |
| Baumann, M | 1 |
| Jin, Y | 1 |
| Ratnam, K | 1 |
| Chuang, PY | 1 |
| Fan, Y | 1 |
| Zhong, Y | 1 |
| Dai, Y | 1 |
| Mazloom, AR | 1 |
| Chen, EY | 1 |
| D'Agati, V | 1 |
| Xiong, H | 1 |
| Ross, MJ | 1 |
| Chen, N | 1 |
| Ma'ayan, A | 1 |
| He, JC | 1 |
| Schnackenberg, LK | 1 |
| Sun, J | 1 |
| Pence, LM | 1 |
| Bhattacharyya, S | 1 |
| Gamboa da Costa, G | 1 |
| Beger, RD | 1 |
| PERKOFF, GT | 1 |
| Siddiqi, NJ | 1 |
| Alhomida, AS | 1 |
| Nakaya, I | 1 |
| Wada, T | 1 |
| Furuichi, K | 1 |
| Sakai, N | 1 |
| Kitagawa, K | 1 |
| Yokoyama, H | 1 |
| Ishida, Y | 1 |
| Kondo, T | 1 |
| Sugaya, T | 1 |
| Kawachi, H | 1 |
| Shimizu, F | 1 |
| Narumi, S | 1 |
| Haino, M | 1 |
| Gerard, C | 1 |
| Matsushima, K | 1 |
| Kaneko, S | 1 |
| Bruno, NE | 1 |
| Yano, Y | 1 |
| Takei, Y | 1 |
| Gabazza, EC | 1 |
| Qin, L | 1 |
| Nagashima, M | 1 |
| Morser, J | 1 |
| D'Alessandro-Gabazza, CN | 1 |
| Taguchi, O | 1 |
| Sumida, Y | 1 |
| Lisá, L | 1 |
| Lacková, E | 1 |
| Jansa, M | 1 |
| Sivanova, LA | 1 |
| Ananenko, AA | 1 |
| Korovina, NA | 1 |
| Abrosimova, NA | 1 |
| Tănase-Mogoş, I | 1 |
| Ciortoloman, H | 1 |
| Petrescu, L | 1 |
| Pâtea, P | 1 |
| Popescu, M | 1 |
| Ankăr, V | 1 |
| Grigorescu, G | 1 |
| D'Amore, M | 1 |
| Quarto, S | 1 |
| Terlizzi, N | 1 |
| Martiradonna, A | 1 |
| Carrozzo, M | 1 |
| Chanard, J | 2 |
| Szymanowicz, A | 2 |
| Brunois, JP | 2 |
| Toupance, O | 2 |
| Melin, JP | 1 |
| Birembaut, P | 2 |
| Randoux, A | 1 |
| Borel, PJ | 2 |
| Niell, HB | 1 |
| Neely, CL | 1 |
| Palmieri, GM | 1 |
| Michael, AF | 1 |
| Brown, DM | 1 |
| Man, M | 1 |
| Nagle, RB | 1 |
| Adams, E | 1 |
| Hecht, A | 1 |
| Gershberg, H | 1 |
| St Paul, H | 1 |
| Bartosch, B | 1 |
| Vycudilik, W | 1 |
| Popow, C | 1 |
| Lubec, G | 1 |
| Kozlowski, H | 1 |
| Hrabowska, M | 1 |
| Bank, H | 1 |
| Crispin, M | 1 |
| Ehrlich, D | 1 |
| Szeinberg, A | 1 |
| Kocher, P | 1 |
| Simon, NM | 1 |
| Bell, NH | 1 |
| Del Greco, F | 1 |
| Herting, W | 1 |
| Liebegott, G | 1 |
| Heller, H | 1 |
| Miyakawa, T | 2 |
| Berger, R | 1 |
| Broyer, M | 1 |
2 reviews available for hydroxyproline and Kidney Diseases
| Article | Year |
|---|---|
[Urinary peptidomics].
Topics: Biomarkers; Chromatography, Liquid; Collagen; Humans; Hydroxyproline; Kidney Diseases; Peptides; Pro | 2010 |
FAMILIAL ASPECTS OF DIFFUSE RENAL DISEASES.
Topics: Amyloidosis; Angiokeratoma; Blood; Congenital Abnormalities; Deafness; Genetics, Medical; Hematuria; | 1964 |
33 other studies available for hydroxyproline and Kidney Diseases
| Article | Year |
|---|---|
Targeting CC chemokine ligand (CCL) 20 by miR-143-5p alleviate lead poisoning-induced renal fibrosis by regulating interstitial fibroblasts excessive proliferation and dysfunction.
Topics: Animals; Cell Proliferation; Chemokines, CC; Female; Fibroblasts; Fibrosis; Humans; Hydroxyproline; | 2022 |
Betaine attenuates sodium arsenite-induced renal dysfunction in rats.
Topics: Animals; Antioxidants; Arsenic; Arsenites; Betaine; Creatinine; Glutathione; Hydroxyproline; Kidney | 2022 |
Twist1 in Infiltrating Macrophages Attenuates Kidney Fibrosis
Topics: Actins; Animals; Benzofurans; Collagen Type I; CX3C Chemokine Receptor 1; Disease Models, Animal; Ex | 2019 |
Novel Omega-3 Fatty Acid Epoxygenase Metabolite Reduces Kidney Fibrosis.
Topics: Actins; Animals; Collagen; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fatty Acids, O | 2016 |
Metabolomics study of renal fibrosis and intervention effects of total aglycone extracts of Scutellaria baicalensis in unilateral ureteral obstruction rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Blood Urea Nitrogen; Creatinine; Discr | 2016 |
Fuzheng Huayu recipe and vitamin E reverse renal interstitial fibrosis through counteracting TGF-beta1-induced epithelial-to-mesenchymal transition.
Topics: Adaptor Proteins, Signal Transducing; Animals; Benzamides; Biological Transport; Cadherins; Collagen | 2010 |
Effect of the inosine 5'-monophosphate dehydrogenase inhibitor BMS-566419 on renal fibrosis in unilateral ureteral obstruction in rats.
Topics: Acridines; Animals; Chemokine CCL2; Chronic Disease; Collagen; Fibrosis; Hydroxyproline; IMP Dehydro | 2010 |
AGE formation blockade with aminoguanidine does not ameliorate chronic allograft nephropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cardiotonic Ag | 2011 |
A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.
Topics: Analysis of Variance; Animals; Apoptosis; Carrier Proteins; Cell Differentiation; Cells, Cultured; C | 2012 |
Metabolomics evaluation of hydroxyproline as a potential marker of melamine and cyanuric acid nephrotoxicity in male and female Fischer F344 rats.
Topics: Animals; Biomarkers; Female; Fibrosis; Hydroxyproline; Kidney Diseases; Male; Metabolomics; Rats; Ra | 2012 |
Effect of mercuric chloride on urinary excretion of free hydroxyproline.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Collagen; Creatinine; Dose-Response Relationship, Drug; H | 2006 |
Blockade of IP-10/CXCR3 promotes progressive renal fibrosis.
Topics: Animals; Antibodies, Monoclonal; Cells, Cultured; Chemokine CXCL10; Chemokines, CXC; Disease Progres | 2007 |
Protective role of thrombin activatable fibrinolysis inhibitor in obstructive nephropathy-associated tubulointerstitial fibrosis.
Topics: Animals; Carboxypeptidase B2; Cytokines; Fibrinolysin; Fibrosis; Hydroxyproline; Kidney Diseases; Ma | 2008 |
[Hydroxyproline in children].
Topics: Adolescent; Child; Child, Preschool; Growth; Humans; Hydroxyproline; Infant; Infant, Newborn; Kidney | 1967 |
[Importance of studying oxyproline and glycosaminoglycans in skin fibroblast culture in the congenital and hereditary kidney diseases of children].
Topics: Cells, Cultured; Child; Diagnosis, Differential; Fibroblasts; Glycosaminoglycans; Histocytochemistry | 1984 |
[Metabolic errors of the cystinuria-lysinuria, cystinosis type detected in the newborn infant and child with renal and ocular diseases].
Topics: Adolescent; Child; Child, Preschool; Cystinosis; Cystinuria; Eye Diseases; Female; Humans; Hydroxypr | 1981 |
[Rarefying osteopathy in rheumatology. Methods of evaluation and comparison of urinary hydroxyproline and serum proline iminopeptidase].
Topics: Adult; Aged; Aminopeptidases; Arthritis, Rheumatoid; Bone Diseases; Female; Humans; Hydroxyproline; | 1980 |
Increased renal excretion of 3 hydroxyproline in patients with active glomerular nephropathies and with polycystic renal disease.
Topics: Acute Kidney Injury; Adult; Glomerulonephritis; Humans; Hydroxyproline; Kidney Diseases; Nephritis, | 1982 |
The postabsorptive urinary hydroxyproline (spot-HYPRO) in patients with multiple myeloma.
Topics: Bone Resorption; Creatinine; Dialysis; Follow-Up Studies; Humans; Hydroxyproline; Kidney Diseases; M | 1981 |
Increased concentration of albumin in kidney basement membranes in diabetes mellitus.
Topics: Adolescent; Adult; Albumins; Basement Membrane; Child; Diabetic Nephropathies; Humans; Hydroxyprolin | 1981 |
Urinary 3-hydroxyproline in renal disease.
Topics: Adolescent; Adult; Creatinine; Glomerulonephritis; Humans; Hydroxyproline; Infant; Kidney Diseases; | 1980 |
Chemical estimation of interstitial and basement membrane collagen in obstructive nephropathy.
Topics: Animals; Basement Membrane; Collagen; Hydroxyproline; Kidney Cortex; Kidney Diseases; Rabbits | 1978 |
Primary hyperparathyroidism. Laboratory and clinical data in 73 cases.
Topics: Adenoma; Adolescent; Adult; Age Factors; Aged; Bone Diseases; Calcium; Depression; Female; Glomerula | 1975 |
Urinary 3-hydroxyproline excretion in Alport's syndrome: a non-invasive screening test?
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Chromatography, Thin Layer; Female; Humans; | 1991 |
[Influence of DL-hydroxyproline on the development of experimental amyloidosis].
Topics: Amyloid; Amyloidosis; Animals; Caseins; Cytoplasm; Female; Hydroxyproline; Hyperplasia; Injections, | 1972 |
Iminoglycinuria. A defect of renal tubular transport.
Topics: Adult; Amino Acids; Chromatography, Paper; Feces; Glycine; Humans; Hydroxyproline; Imines; Kidney Di | 1972 |
[Study of urinary hydroxyproline in osteopathies].
Topics: Acromegaly; Adult; Aged; Bone Neoplasms; Female; Humans; Hydroxyproline; Hyperparathyroidism; Hypert | 1966 |
Iminoacidopathy in renal failure.
Topics: Calcium; Glycine; Humans; Hydroxyproline; Hyperparathyroidism, Secondary; Kidney Diseases; Kidney Fa | 1970 |
[Congenital familial osteopetrosis (marble bone disease Albers-Schönberg). A contribution to the pathogenesis].
Topics: Albuminuria; Amino Acids; Anemia; Autopsy; Bone and Bones; Female; Goiter; Humans; Hydroxyproline; H | 1971 |
[Congenital phophaturia, its causes and consequences].
Topics: Adolescent; Alkaline Phosphatase; Blood Sedimentation; Bone Diseases; Humans; Hydroxyproline; Kidney | 1967 |
Studies on the alterations in glucosamine, galactosamine and hydroxyproline contents of the kidney, liver, serum and urine in experimental renal disease.
Topics: Animals; Chromatography; Glucosamine; Hexosamines; Hydroxyproline; Kidney; Kidney Diseases; Liver; R | 1968 |
[Hyperprolinemia and hydroxyprolinemia].
Topics: Amino Acid Metabolism, Inborn Errors; Child; Collagen; Consanguinity; Female; Genes, Recessive; Glyc | 1969 |
[Studies on the alterations in glucosamine, galactosamine and hydroxyproline contents of kidney, liver, serum and urine in experimental renal disease].
Topics: Animals; Blood; Galactose; Glucosamine; Hydroxyproline; Kidney; Kidney Diseases; Liver; Urine | 1965 |